Histone Deacetylase Inhibitors Sensitize TRAIL-Induced Apoptosis in Colon Cancer Cells

Baojie Zhang1, Bin Liu2, Deng Chen3

  • 1Department of Chemical and Pharmaceutical Biology, Groningen Research Institute of Pharmacy, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands. b.z.zhang@rug.nl.

Cancers
|May 15, 2019
PubMed

Insights

Targeted histone deacetylase inhibitors (HDACi) combined with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) variants effectively overcome TRAIL resistance in colon cancer. This combination therapy shows promise for treating resistant colon cancers, including in 3D models.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a potential anti-cancer therapeutic but faces resistance in many cancers.
  • Broad-spectrum histone deacetylase inhibitors (HDACi) show toxicity, limiting clinical application.
  • Class I histone deacetylases (HDACs) are overexpressed in colon tumors, suggesting targeted inhibition as a strategy.

Purpose of the Study:

  • To investigate the efficacy of combining specific class I HDAC inhibitors with TRAIL variants to overcome TRAIL resistance in colon cancer cells.
  • To explore the role of specific HDACs (HDAC1, 2, 3, 8) in TRAIL-induced apoptosis.
  • To evaluate the therapeutic potential of this combination in 3D tumor spheroid models.

Main Methods:

  • Treatment of TRAIL-resistant colon cancer cell lines (DLD-1, WiDr) with specific class I HDAC inhibitors (Entinostat, RGFP966, PCI34051) and TRAIL variants (rhTRAIL 4C7, DHER).
  • Assessment of apoptosis induction via TRAIL-mediated pathways.
  • Gene silencing (knockdown) of HDAC1, 2, and 3 to confirm their roles.
  • Analysis of death receptor (DR4, DR5) expression.
  • Evaluation in 3D tumor spheroid models.

Main Results:

  • Entinostat, RGFP966, or PCI34051 significantly enhanced TRAIL-induced apoptosis in WiDr and DLD-1 cells.
  • HDAC1, 2, or 3 knockdown increased early apoptotic cells upon TRAIL variant treatment.
  • RGFP966 and PCI34051 modulated DR4 and DR5 expression differently in DLD-1 and WiDr cells.
  • Combined treatment of RGFP966 with TRAIL variants increased apoptosis in 3D tumor spheroid models.

Conclusions:

  • Specific class I HDAC inhibitors (RGFP966, PCI34051) combined with TRAIL variants represent a novel and effective strategy against TRAIL-resistant colon cancer.
  • Targeting HDAC3 or HDAC8, in particular, shows promise for enhancing TRAIL therapy.
  • This combination therapy demonstrates efficacy in preclinical 3D models, warranting further investigation.

Related Concept Videos

Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
16.0K
Histone Modification02:32

Histone Modification

4.4K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.9K
Histone Variants at the Centromere02:30

Histone Variants at the Centromere

Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
5.0K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
14.2K
The Colonization of Land02:22

The Colonization of Land

Changes in the environment of the early Earth drove the evolution of organisms. As prokaryotic organisms in the oceans began to photosynthesize, they produced oxygen. Eventually, oxygen saturated the oceans and entered the air, resulting in an increase in atmospheric oxygen concentration, known as the oxygen revolution approximately 2.3 billion years ago. Therefore, organisms that could use oxygen for cellular respiration had an advantage. More than 1.5 years ago, eukaryotic cells and...
37.5K